Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
10.4 USD | -0.38% | -5.54% | +20.09% |
05-24 | JPMorgan Adjusts Price Target on Cellebrite DI to $14 From $12, Maintains Overweight Rating | MT |
05-24 | Deutsche Bank Adjusts Price Target on Cellebrite to $15 From $13, Maintains Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+20.09% | 2.14B | |
+10.66% | 3,092B | |
+9.13% | 86.07B | |
+5.43% | 78.64B | |
-14.91% | 53.11B | |
+28.71% | 49.21B | |
+31.31% | 46.21B | |
-33.61% | 41.11B | |
+73.04% | 40.25B | |
+3.06% | 28.44B |
- Stock Market
- Equities
- CLBT Stock
- News Cellebrite DI Ltd.
- Cellebrite DI Swings to Q2 Adjusted Earnings, Revenue Increases; Raises 2023 Sales Outlook